PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
33 hedge funds and large institutions have $106M invested in PDL BioPharma, Inc. in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 103 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
76% less call options, than puts
Call options by funds: $63K | Put options by funds: $268K
95% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 103
Holders
33
Holding in Top 10
1
Calls
$63K
Puts
$268K
Top Buyers
| 1 | +$42.9M | |
| 2 | +$12.9M | |
| 3 | +$1.56M | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$1.27M |
| 5 |
JC
JBF Capital
Aspen,
Colorado
|
+$971K |
Top Sellers
| 1 | -$30.9M | |
| 2 | -$29.4M | |
| 3 | -$23.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$16.6M |